Zobrazeno 1 - 2
of 2
pro vyhledávání: '"M. A. Telyashov"'
Autor:
M. Y. Drokov, T. V. Gaponova, T. Y. Gubenko, O. S. Karavaeva, M. A. Telyashov, A. S. Antimonov, V. V. Zubkov, E. N. Parovichnikova
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 2 (2023)
Despite their widespread clinical implementation, chimeric antigen receptor T-cell (CAR-T) therapy products, including those manufactured by industrial processes, are still not legally available or used in the Russian Federation.The aim of the study
Externí odkaz:
https://doaj.org/article/d7e8f7f98cc847dbb414672bcb4b8841
Autor:
E. E. Zvonkov, D. A. Koroleva, N. G. Gabeeva, A. E. Shchekina, M. A. Telyashov, O. A. Aleshina, B. V. Biderman, A. B. Sudarikov, T. N. Obukhova, I. V. Galtseva, V. N. Dvirnik, V. V. Troitskaya, G. M. Galstyan, M. A. Maschan, E. N. Parovichnikova
Publikováno v:
Russian journal of hematology and transfusiology. 67:441-452
Introduction. The tactics of therapy for elderly comorbid patients with mantle cell lymphoma with unfavorable prognosis factors (complex karyotype, 17p13 deletion, mutations in the TP53 gene) have not been developed. The use of intensive chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f76e06130fddea68f0e1c020d3e25725
https://doi.org/10.35754/0234-5730-2022-67-3-441-452
https://doi.org/10.35754/0234-5730-2022-67-3-441-452